The WACC of Newron Pharmaceuticals SpA (NWRN.SW) is 5.2%.
| Range | Selected | |
| Cost of equity | 4.20% - 6.20% | 5.20% |
| Tax rate | 0.10% - 0.20% | 0.15% |
| Cost of debt | 4.00% - 7.00% | 5.50% |
| WACC | 4.1% - 6.4% | 5.2% |
| Category | Low | High |
| Long-term bond rate | 1.0% | 1.5% |
| Equity market risk premium | 5.1% | 6.1% |
| Adjusted beta | 0.43 | 0.53 |
| Additional risk adjustments | 1.0% | 1.5% |
| Cost of equity | 4.20% | 6.20% |
| Tax rate | 0.10% | 0.20% |
| Debt/Equity ratio | 0.25 | 0.25 |
| Cost of debt | 4.00% | 7.00% |
| After-tax WACC | 4.1% | 6.4% |
| Selected WACC | 5.2% | |